Rebooting the immune system

Israel’s NeoTX (see here previously) is now conducting a Phase 2 trial of its naptumomab estafenatox (NAP) bacteria-coated, immunotherapy cancer treatment on 30 patients in the US. It is also enhancing an AstraZeneca checkpoint inhibitor. NeoTX has 3 Nobel prizewinners in its team.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *